KYMR
Kymera Therapeutics, Inc.
$119.24
+4.48 (+3.90%)
At close · Jul 7
Market Cap
$9.81B
Shares
82,257,588
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-25 | — | |
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-08 | 2026-06-05 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-29 | 2026-06-24 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-27 | 2026-03-25 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2025-12-10 | 2025-12-08 | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-09-03 | 2025-08-27 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-06-27 | 2025-06-25 | |
| 8-K | 2025-06-27 | 2025-06-25 | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-06-02 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-29 | 2025-06-25 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-14 | — | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-08-20 | 2024-08-19 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-07-08 | — | |
| 8-K | 2024-06-20 | 2024-06-18 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-18 | |
| 8-K | 2024-04-01 | 2024-03-28 | |
| 8-K | 2024-02-22 | — | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2024-01-04 | — |
Showing 1–50 of 105 filings